Kahatano A.E, Mpina M, Vanobberghen F, Hassan O, Urasa N, Sasamalo I, Mswata S, Paris D, Gajewski S, Saxena M, Fürle K, Kiehl V, Böhnlein E, Aschenbrenner A, Lanzer M, Thomson-Luque R, Olotu A, Daubenberger C. Full-length merozoite surface protein 1 formulated with GLA-SE adjuvant in malaria pre-exposed adults: a randomised, controlled, double-blind, parallel-group, single-centre Phase Ib trial. EClinicalMedicine. 2025;89:103585. DOI: 10.1016/j.eclinm.2025.103585

2025
Journal Article
PubMed